A detailed history of Cutter Capital Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cutter Capital Management, LP holds 574,057 shares of BMY stock, worth $33.4 Million. This represents 8.77% of its overall portfolio holdings.

Number of Shares
574,057
Holding current value
$33.4 Million
% of portfolio
8.77%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $22.8 Million - $29.7 Million
574,057 New
574,057 $29.7 Billion
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $14.7 Million - $16.7 Million
306,900 Added 219.21%
446,900 $24.2 Billion
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $6.79 Million - $8.1 Million
140,000 New
140,000 $7.18 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.